Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?

PURPOSE: An estimated 10% of breast and ovarian cancers result from hereditary causes. Current testing guidelines for germ line susceptibility genes in patients with breast carcinoma were developed to identify carriers of BRCA1/2 variants and have evolved in the panel-testing era. We evaluated the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Beitsch, Peter D., Whitworth, Pat W., Hughes, Kevin, Patel, Rakesh, Rosen, Barry, Compagnoni, Gia, Baron, Paul, Simmons, Rache, Smith, Linda Ann, Grady, Ian, Kinney, Michael, Coomer, Cynara, Barbosa, Karen, Holmes, Dennis R., Brown, Eric, Gold, Linsey, Clark, Patricia, Riley, Lee, Lyons, Samuel, Ruiz, Antonio, Kahn, Sadia, MacDonald, Heather, Curcio, Lisa, Hardwick, Mary Kay, Yang, Shan, Esplin, Ed D., Nussbaum, Robert L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
RAPID COMMUNICATION
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380523/
https://www.ncbi.nlm.nih.gov/pubmed/30526229
http://dx.doi.org/10.1200/JCO.18.01631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380523/
https://www.ncbi.nlm.nih.gov/pubmed/30526229
http://dx.doi.org/10.1200/JCO.18.01631

Ejemplares similares